The White House Office of Management and Budget has proposed a more-than-400-page rule that would place nearly $1 trillion in federal grants under political-appointee control by October, requiring grants to “demonstrably advance the president’s policy priorities,” banning diversity, equity and inclusion programs, prohibiting undefined “anti-American values,” and permitting cancellation of awards no longer in the federal government’s “interest.” Published in the Federal Register on May 29, 2026, the rule drew nearly 500,000 public comments during a 45-day period that closed the week of July 20; analyses by STAT/UNC and Tech Policy Press classified roughly 94 to 95 percent of those submissions as opposed. Twenty-two state attorneys general have mobilized against the proposal. Lawrence Gostin, a professor of global public health at Georgetown Law, called the compressed comment window “a subterfuge for moving ahead when they’re really not interested in what the comments say.”

The rule’s authority structure

The proposal’s operational core is the relationship between political appointees and grant recipients. Appointees would replace peer-review and formula-based allocation with direct ideological enforcement. The “federal interest” cancellation provision — drawn from Executive Order 14332, which permits termination “if the award no longer advances agency priorities or the national interest” — gives that enforcement teeth.

The relationship mapping of the actors and institutions involved reveals a hub-and-spoke topology with OMB as the political-control hub. Three constraint layers cascade downward: ideological gates at the rule-text level (the DEI prohibition, the “presidential priorities” requirement, the ban on undefined “anti-American values”), appointee enforcement authority at the agency level, and compliance burden on grant recipients. The structure concentrates accountability upward to political appointees interpreting rules with few discernible criteria, while distributing risk downward to recipients who cannot stabilize funding against a standard they cannot see. In a peer-reviewed system, an applicant knows the criteria — scientific merit, methodological rigor, institutional capacity — because reviewers justify their judgments against published standards. Under the proposed rule, accountability runs solely to political appointees’ interpretation, and applicants face a set of terms the proposal does not define. “Anti-American values” is not a standard. It is a blank space into which whoever reviews the application writes their own judgment.

Krieger’s experience in spring 2025 — when her NIH R-01 grant on discrimination and population health was canceled via email — is not speculative precedent. It is a documented instance of the pattern the rule codifies. The administration’s first year saw DOGE target research on gender, race, and equity, as well as programs attempting to reach underserved communities. The proposed rule would institutionalize that upheaval as permanent regulation, formalizing what had been ad hoc ideological enforcement into a binding framework. Of the affected total, roughly $150 billion is typically invested in science and technology — a figure whose derivation from the proposal’s categories is not independently specified in the rule text. The National Institutes of Health, the world’s largest public funder of biomedical and behavioral research, operates on a $47 billion budget.

The rule’s internal architecture produces four Major-severity vulnerabilities.

Undefined criteria. The rule prohibits “anti-American values” with no definition across 400-plus pages, permits cancellation when an award no longer serves the federal government’s “interest” with no standard supplied, and requires demonstration of presidential “policy priorities” with no measurement criteria. The scale amplifies the vulnerability: roughly $150 billion in science and technology funding alone makes arbitrary denial a non-trivial harm. Within the executive-prerogative paradigm, “anti-American values” is a filled category — the administration genuinely believes it knows what values are un-American and sees no need to define the self-evident. But the absence of any definition across 400-plus pages means the term functions as open-ended delegation regardless of what the administration “genuinely believes” it means, and that delegation is the precise vulnerability that due-process and nondelegation challenges target.

Comment-period compression. Forty-five days for a rule of this magnitude, compared to the 60-to-90-day standard for rules of similar scope, drew nearly 500,000 submissions with analyses showing as much as 95 percent in opposition. Under the Administrative Procedure Act (5 U.S.C. § 553), a procedurally defective record is challengeable regardless of substantive merits — a court can act on process defect without wading into policy content. The same actors who designed the rule controlled the comment timeline and have publicly characterized opposition as a “freakout.” OMB Director Russell Vought dismissed nonprofit opposition on social media as a “freakout by those on the left.” The White House “fraud taskforce” did not frame the comments as a democratic input that deserved engagement; it framed the rule as a corrective measure that the comments confirmed needed. The comment mechanism functioned as a recorded-dissent instrument, not a decision-influencing channel.

Attribution opacity on the 95 percent figure. The source article’s attribution chain for the opposition metric terminates at the news outlet rather than at the named independent analyses — STAT/UNC and Tech Policy Press — that produced the figure. The vulnerability is not that the number is wrong; it has been independently corroborated across multiple secondary sources. It is that a downstream consumer cannot assess comment-period self-selection bias or methodological provenance from the article alone.

Absent adversarial voice in the source record. Five opponents are quoted at length — Krieger, Rosenbaum, Gostin, Bonta, Baldwin — while Heritage Foundation support appears in a single sentence with no direct quote and no articulation of the rule’s intended function beyond the “woke NGOs with partisan agendas” characterization. The Heritage Foundation, the Washington, D.C., think tank that authored Project 2025, supports the rule. OMB Director Vought’s alignment with Heritage creates a plausible influence pathway, but the exact causal path from Heritage’s policy architecture to the rule’s text is not established in available materials. A reader encounters no account of what the administration argues the rule is for. The absence of a public defense does not establish that no defensible one exists — a strongest-case defense might argue that undefined terms preserve flexibility across an enormously varied grant portfolio and that presidential priorities are the only democratic check on a grant-making system that has operated without electoral accountability for decades — but it means the analytical record cannot evaluate it.

Three Caveat-severity findings further qualify the picture. Pre-enforcement cancellations — Krieger’s being the documented example, with each cancellation backed by the NIH communication that issued it and the researcher’s institutional affiliation — create a plaintiff pool that accelerates litigation. The legal-viability framing in the source article, in which Gostin’s predictions are presented with equal structural weight to concrete factual claims, requires readers to distinguish established facts from contingent expert prediction. And the judicial-path limitation Gostin himself names means that procedural wins at trial may be reversed on appeal.

Three paradigms, one collapsed frame

A worldview cartography of the dispute reveals three paradigms competing to define what grant-making means. They are not debating the same question. The first asks: is this good science? The second asks: does this serve the president’s priorities? The third asks: is this legal? An action can be legal and bad for science; it can be good science and beyond executive authority. The proposal’s significance lies in its attempt to answer all three questions by collapsing them into one: the executive-prerogative frame’s answer.

The scientific-autonomy paradigm, inhabited by researchers including Krieger and George Washington University professor emerita Sara Rosenbaum, sees grants as scientific investment allocated by peer-reviewed merit. Its vocabulary — “peer review,” “censorship,” “breakthrough or cure” — treats political interference as a corruption of a system meant to produce knowledge independent of political convenience. Krieger described the administration’s actions as “blunt use of power to put forward the ideological agenda.” Baldwin framed taxpayer expectations in outcome terms: “research that has the best chance at delivering a breakthrough or cure for a disease.” The paradigm’s core positive claim: the government’s role is to fund the best science, not to decide which science is best. Rosenbaum, professor emerita of health law and policy at the Milken Institute School of Public Health at George Washington University, described the rule’s scope as reaching “healthcare, education, social services, environmental protections—it’s way, way beyond just research.” This paradigm has a genuine blind spot: the 1945 federal research bargain was itself a political construct, and “merit” is an institutionally constructed category, not a transcultural neutral. But the paradigm’s structural weakness is that the executive-prerogative critique of “captured peer review” can only be adjudicated within peer review — which is the very institution being challenged.

The executive-prerogative paradigm, inhabited by Vought and the Heritage Foundation, sees grants as policy implementation instruments, with political appointees as the legitimate channel of democratic accountability. Its vocabulary — “demonstrably advance the president’s policy priorities,” “woke NGOs with partisan agendas” — treats peer review as an ideologically captured gatekeeping mechanism. This is the paradigm that collapsed the other two framings into itself. Its structural vulnerability is not political; it is legal.

The constitutional-legal paradigm, inhabited by the 22 state attorneys general and Gostin, sees grants as statutory execution bounded by the APA, the Spending Clause, and appropriations law. Its vocabulary — “standing,” “arbitrary and capricious,” “enjoin,” “weaponize” — treats the legal question as separate from the political one. Bonta’s statement that “the Trump administration is once again attempting to weaponize essential federal funding to advance its policy priorities” captures the paradigm’s framing: this is a question of authority, not of merit. The paradigm offers a dispute-resolution mechanism — litigation — but that mechanism’s outcome depends on which paradigm the reviewing court itself inhabits. Gostin’s own acknowledgment — “not a 100% slam-dunk” and “less certain” as cases move through “highly conservative courts of appeal and the conservative supreme court” — is an acknowledgment that the judicial paradigm may share the executive-prerogative framework’s assumptions about presidential authority.

These paradigms produce structurally incompatible claims about identical objects. Paradigm A reads “anti-American values” as an empty signifier licensing arbitrary censorship; Paradigm B reads it as a substantive category filled by the administration’s own value framework. The structural finding — not the paradigmatic position — is that the absence of any definition in 400-plus pages makes the term an open-ended delegation instrument, and that instrument is what the courts will adjudicate. Paradigm A’s peer review is Paradigm B’s captured peer review. The 45-day comment period that Paradigm A sees as inadequate and Paradigm C sees as legally actionable may be, within Paradigm B’s corrective logic, entirely sufficient — but the procedural record’s sufficiency is a legal question, not a matter of paradigm-internal preference.

The pre-existing plaintiff base and the judicial trajectory

Gostin expects lawsuits from state attorneys general, institutions, and possibly individual plaintiffs. He noted that a lawsuit would likely need a grant denial to establish standing. Krieger already has one. The 22-state attorneys general coalition, led by Bonta, has already signaled its opposition formally and urged OMB to withdraw the proposal. The pre-enforcement cancellation pattern means a factual record of specific, named denials — each backed by the NIH communication that issued it — already exists, accelerating the litigation timeline in ways that a challenge to a brand-new rule would not support.

A nondelegation argument — the claim that the rule delegates standard-setting authority without an intelligible principle — has grounding in doctrine. The undefined terms in the proposal, taken together, leave applicants unable to know the standard their application will be judged against. But the nondelegation doctrine has been applied inconsistently; its reach in this context is uncertain. Gostin predicted that district court judges may enjoin the rule. “But as it goes through highly conservative courts of appeal and the conservative supreme court, the outcome is less certain.” The procedural vulnerability — the compressed comment period, the absence of defined standards — is strong at trial. Whether it survives appellate review depends on a judicial-philosophy question the rule itself does not control: whether the current Supreme Court’s skepticism of administrative discretion applies to a rule that concentrates discretion rather than constrains it. The red-team assessment identified this as the judicial-path limitation: procedural wins at trial buy months; a structural win requires Congress, and the current political alignment makes that path structurally unavailable.

Open questions

Several questions remain open and will shape what happens next.

  • What happens when courts are asked to review a standard that was never defined in 400 pages? Does “anti-American values” survive as a term of art or collapse under nondelegation scrutiny? And if a district court enjoins the rule on procedural grounds, finding the 45-day comment period inadequate, does that injunction hold through appellate review, or does the compressed timeline survive scrutiny in courts that may share the administration’s view of executive discretion?
  • How does the 95-percent opposition figure function in a legal record? Comment-period self-selection limits its reach as a measure of broader public opinion — the people who comment on federal rules are not a random sample — but as evidence that meaningful engagement with the rule’s scope was structurally precluded by the compressed timeline, it may carry significant procedural weight. The content of the roughly 5 percent of supportive comments is unknown; the procedural record’s strength depends on whether those comments argued substantive engagement the agency could cite.
  • What, exactly, are the terms under which a political appointee could cancel a $47 billion research portfolio? The rule supplies the authority. It does not supply the standard. Whether that gap is a feature of executive flexibility or a defect of unconstitutional delegation is the question the courts will have to answer — and the answer may depend less on doctrine than on which judge is asking.
  • The rule’s $1 trillion scope is not disaggregated between discretionary and mandatory spending in available sources, a gap that matters for assessing the actual extent of political-appointee control. The specific statutory authorization of the rule is not identified in source material and would affect the scope of nondelegation review available to litigants. The Federal Register publication timeline for the final rule is not specified; the window for pre-enforcement review depends on it.
  • Whether additional NIH cancellations occurred beyond Krieger’s spring 2025 instance is not specified in source material; the pre-enforcement plaintiff-pool size is therefore inferred, not documented.

Analytical techniques used in this piece

This analysis applies the methods below. Each links to a short, plain-English explainer you can read and reuse.

Red-Team Assessment
Models a capable adversary probing a plan for the seams they would exploit.
Relationship Mapping
Extracts the network of ties among people, institutions, and entities.
Worldview Cartography
Maps the clashing worldviews underlying a dispute.